The global irinotecan market is expected to grow at a CAGR of 5.5% from 2022 to 2029. The market growth is attributed to the increasing incidence of cancer, rising demand for novel therapeutics, and growing awareness about cancer treatments. By type, the irinotecan hydrochloride injection 40mg segment is expected to account for the majority share […]
